Skip to main content
Log in

Depression of cell-mediated immunity by tumour cell products: induction of resistance by immunotherapeutically active extracts of bovine ocular squamous cell carcinoma

  • Original Articles
  • Published:
Cancer Immunology, Immunotherapy Aims and scope Submit manuscript

Summary

Tumours produce substances that inhibit the expression of cell-mediated immunity, in the form of delayed-type hypersensitivity in mice. Phenol-saline extracts of bovine ocular squamous cell carcinoma (BOSCC) which have immunotherapeutic activity in cattle were able to immunize mice against this depressive effect. Such immunization was effective against products of BOSCC, a spontaneous rat tumour, three of four human tumour cell lines and (in other experiments) mouse tumours. Phenol-saline extracts of mouse tumour cell lines were immunogenic (protective against depression of delayed-type hypersensitivity) in mice. Fractions of BOSCC phenol-saline extracts which were immunotherapeutically active in cattle were generally also protective in mice. The protective activity was lost after treatment with proteinase K, and was present in the supernatant after precipitation with 55% ammonium sulphate. It was not affected by treatment with RNase or DNase or by heating to 50 °C for 2 h. It was present in gel filtration fractions with an apparent molecular weight of 10,000–37,000 daltons. The immunogenic factor in mice and the immunotherapeutic factor in cattle may be related to each other.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Akiyama M, Bean MA, Sadamoto K, Takahashi Y, Brankovan V (1983) Suppression of the responsiveness of lymphocytes from cancer patients triggered by co-culture with autologous tumor-derived cells. J Immunol 131:3085

    Google Scholar 

  2. Bradford MM (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248

    Article  CAS  PubMed  Google Scholar 

  3. Cianciolog GJ, Hunter J, Silva J, Haskill JS, Snyderman R (1981) Inhibitors of monocyte responses to chemotaxis are present in human cancerous effusions and react with monoclonal antibodies to the p15E structural protein of retroviruses. J Clin Invest 68:831

    Google Scholar 

  4. Cianciolo GJ, Copeland TD, Oroszlan S, Snyderman R (1985) Inhibition of lymphocyte proliferation by a synthetic peptide homologous to retroviral envelope proteins. Science 230:453

    Google Scholar 

  5. Farram E, Nelson M, Nelson DS, Moon DK (1982) Inhibition of cytokine production by a tumour cell product. Immunology 46:603

    Google Scholar 

  6. Fauve RM, Hevin B, Jacob H, Gailllard JA, Jacob F (1974) Anti-inflammatory effects of murine malignant cells. Proc Natl Acad Sci USA 71:4052

    Google Scholar 

  7. Halliday WJ, Maluish AE, Stephenson PM, Davis NC (1977) An evaluation of leukocyte adherence inhibition in the immunodiagnosis of colorectal cancer. Cancer Res 37:1962

    Google Scholar 

  8. Hersey P, Bindon C, Czernieski M, Spurline A, Wass J, McCarthy WH (1983) Inhibition of interleukin 2 production by factors released from tumour cells. J Immunol 131:2837

    Google Scholar 

  9. Hoffmann D, Jennings PA, Spradbrow P (1981) Immunotherapy of bovine ocular squamous cell carcinomas with phenolsaline extracts of allogeneic carcinomas. Aust Vet J 57:159

    Google Scholar 

  10. Kamo I, Friedman H (1977) Immunosuppression and the role of suppressive factors in cancer. Adv Cancer Res 25:271

    Google Scholar 

  11. Kuchroo VK, Jennings PA, Spradbrow PB (1983) Bovine ocular squamous cell carcinoma: tumor associated immunity detected by E-rosette augmentation test. J Natl Cancer Inst 70:305

    Google Scholar 

  12. Lagrange PH, Mackaness GB, Miller TE (1974) Influence of dose and route of injection on the immunological induction of T cells. J Exp Med 139:528

    Google Scholar 

  13. Mitsuoka A, Teramutsu T, Baba M, Morikawa S, Yasuhira K (1978) Delayed hypersensitivity in mice induced by intravenous sensitization with sheep erythrocytes: Evidence for tuberculin type delayed hypersensitivity of the reaction. Immunology 34:363

    Google Scholar 

  14. Nelson M, Nelson DS (1978) Macrophages and resistance to tumours. I. Inhibition of delayed-type hypersensitivity reactions by tumour cells and by soluble products affecting macrophages. Immunology 34:277

    Google Scholar 

  15. Nelson DS, Nelson M, Farram E, Inoue Y (1981) Cancer and subversion of host defences. Aust J Exp Biol Med Sci 59:229

    Google Scholar 

  16. Nelson M, Nelson DS (1980) Macrophages and resistance to tumours. IV. Influence of age on susceptibility of mice to anti-inflammatory and anti-macrophage effects of tumor cell products. J Natl Cancer Inst 65:781

    Google Scholar 

  17. Nelson M, Nelson DS, Spradbrow PB, Kuchroo VK, Jennings PA, Cianciolo GJ, Snyderman R (1985) Successful tumour immunotherapy: possible role of antibodies to anti-inflammatory factors produced by neoplasms. Clin Exp Immunol 61:109

    Google Scholar 

  18. Normann SJ, Cornelius J (1982) Characterization of anti-inflammatory factors produced by murine tumor cells in culture. J Natl Cancer Inst 69:1321

    Google Scholar 

  19. Orosz CG, Zinn NE, Olsen RG, Mathes LE (1985) Retrovirus-mediated immunosuppression. I. FeLV-UV and specific FeLV proteins alter T lymphocyte behavior by inducing hyporesponsiveness to lymphokines. J Immunol 134:3396

    Google Scholar 

  20. Orosz CG, Zinn NE, Olsen RG, Mathes LE (1985) Retrovirus-mediated immunosuppression. II. FeLV-UV alters in vitro murine T lymphocyte behavior by reversibly impairing lymphokine secretion. J Immunol 135:583

    Google Scholar 

  21. Pike MC, Snyderman R (1976) Depression of macrophage function by a factor produced by neoplasms: a mechanism for abrogation of immune surveillance. J Immunol 117:1243

    Google Scholar 

  22. Roth JA, Osborne BA, Ames RS (1983) Immunoregulatory factors derived from human tumors II. Partial purification and further immunobiochemical characterization of a human sarcoma-derived immunosuppressive factor expressing HLA-DR and immunoglobulin-related determinants. J Immunol 130:303

    Google Scholar 

  23. Snyderman R, Cianciolo GJ (1984) Immunosuppressive activity of the retroviral envelope protein p15E and its possible relationship to neoplasia. Immunol Today 5:240

    Google Scholar 

  24. Spradbrow PB, Wilson BE, Hoffman D, Kelly WR, Francis J (1977) Immunotherapy of bovine occular squamous cell carcinomas. Vet Rec 100:376

    Google Scholar 

  25. Taramelli D, Fossati G, Balsari A, Marolda R, Parmiani G (1984) The inhibition of lymphocyte stimulation by autologous human metastatic melanoma cells correlates with the expression of HLA-DR antigens on the tumor cells. Int J Cancer 34:797

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Nelson, M., Nelson, D.S., Kuchroo, V.K. et al. Depression of cell-mediated immunity by tumour cell products: induction of resistance by immunotherapeutically active extracts of bovine ocular squamous cell carcinoma. Cancer Immunol Immunother 24, 231–236 (1987). https://doi.org/10.1007/BF00205635

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00205635

Keywords

Navigation